Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens

Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes

(2016) Seyyed Mohammad Reza Kazemi-Bajestani et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer

(2015) B.H.L. Tan et al.   EJSO

Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer

(2015) Bjørg Sjøblom et al.   LUNG CANCER

Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer

(2015) O. Arrieta et al.   ONCOLOGIST

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

(2014) A. L. Wong et al.   BREAST CANCER RESEARCH AND TREATMENT

Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

(2014) Maximilien Barret et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial

(2013) Marc Ychou et al.   ANNALS OF SURGICAL ONCOLOGY

Low skeletal muscle is associated with toxicity in patients included in phase I trials

(2013) Sophie Cousin et al.   INVESTIGATIONAL NEW DRUGS

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial

(2011) E. Assenat et al.   ONCOLOGIST

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

The Meaning and Measurement of Lean Body Mass

(2010) Ronenn Roubenoff et al.   NUTRITION REVIEWS

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

(2009) C. M.M. Prado et al.   CLINICAL CANCER RESEARCH

The emerging role of computerized tomography in assessing cancer cachexia

(2009) Carla MM Prado et al.   Current Opinion in Supportive and Palliative Care

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY